Volume 1 Supplement 1

Abstracts of the 50th Workshop for Pediatric Research

Open Access

A novel mutation in the PAX8 promoter region causes permanent congenital hypothyroidism in a patient with Down’s Syndrome

  • Pia Hermanns1,
  • Sunia Khadouma1,
  • Scott Shepherd2,
  • Mohamed Mansor3,
  • John Schulga3,
  • J Jones2,
  • M Donaldson2 and
  • Joachim Pohlenz1
Molecular and Cellular Pediatrics20141(Suppl 1):A24

https://doi.org/10.1186/2194-7791-1-S1-A24

Published: 11 September 2014

Thyroid dysfunction is common in newborn infants with Down’s syndrome (DS) but defects in organogenesis have not been described. A female infant was diagnosed to have trisomy 21, atrio-ventricular septal defect and patent ductus. Newborn screening showed capillary TSH 43.8 mU/L(day 5), venous TSH >150 mU/l and free T4 15.1 pmol/L (day 12). Thyroid ultrasound showed a small gland with heterogenous echotexture and cystic changes. Scintigraphy showed normal uptake into an eutopic gland. The infant was treated with thyroxine and underwent cardiac repair at 69 days. Sequencing analysis of candidate genes involved in thyroid development revealed a new heterozygous mutation close to the transcription initiation site of the PAX8 gene. Electromobility shift assay (EMSA) studies exhibited that the sequence at this position is not involved in specific protein binding. However, the mutant PAX8 promoter showed a significantly reduced transcriptional activation of a luciferase reporter gene in vitro tested in HEK, PCCL3 as well as in HeLa cells indicating that the mutation is very likely to lead to a reduced PAX8 gene expression. Further study in infants with DS and TSH elevation are indicated to investigate whether or not there is a true association between DS and PAX8 mutations.

Authors’ Affiliations

(1)
Department of Pediatrics, Johannes Gutenberg University Medical School
(2)
Child Health Unit, School of Medicine, Royal Hospital for Sick Children
(3)
Department of Paediatrics, Forth Valley Royal Hospital

Copyright

© Hermanns et al; licensee Springer 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.